Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CymaBay Therapeutics Inc. (CBAY)

12.62   -0.36 (-2.77%) 05-17 16:00
Open: 12.93 Pre. Close: 12.98
High: 13 Low: 12.45
Volume: 911,975 Market Cap: 867M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.007 - 13.074 13.074 - 13.125
Low: 12.298 - 12.367 12.367 - 12.419
Close: 12.511 - 12.626 12.626 - 12.715

Technical analysis

as of: 2019-05-17 4:27:15 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 15.83     One year: 18.49
Support: Support1: 12.36    Support2: 11.63
Resistance: Resistance1: 13.55    Resistance2: 15.83
Pivot: 12.83
Moving Average: MA(5): 12.77     MA(20): 12.78
MA(100): 11.23     MA(250): 11.38
MACD: MACD(12,26): 0.04     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 61.48     %D(3): 61.60
RSI: RSI(14): 48.03
52-week: High: 15.00  Low: 6.31  Change(%): -2.0
Average Vol(K): 3-Month: 73185  10-Days: 67998

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CBAY has closed above bottom band by 31.9%. Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CBAY's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 17 May 2019 21:10:22 Z
Noteworthy Friday Option Activity: MDGL, CBAY, QCOM

Fri, 01 Mar 2019 06:07:18 Z
CymaBay Therapeutics Inc (CBAY) Q4 2018 Earnings Conference Call Transcript

Wed, 19 Sep 2018 14:40:17 Z
Sum Up The Pieces: DWAS Could Be Worth $66

Tue, 28 Aug 2018 18:53:03 Z
Oppenheimer’s 7 Top Stock Picks for September

Thu, 26 Jul 2018 12:09:23 Z
New Strong Sell Stocks for July 26th

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 68.69
Shares Float (M) 68.28
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.280
EPS Est. Current Year -0.820
EPS Est. Next Year -0.740
EPS Est. Next Quarter -0.160
Forward EPS -0.940
Book Value (p.s.) 3.430
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -31.0
Return on Equity (ttm) -33.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -70.89
Levered Free Cash Flow (M) -49.78

Stock Valuations

P/E -9.86
P/E Growth Ratio -0.03
P/BV 3.68
P/CF -12.23

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.